IRIDEX Operating Income 2010-2023 | IRIX
IRIDEX operating income from 2010 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
IRIDEX Annual Operating Income
(Millions of US $) |
| 2023 |
$-10 |
| 2022 |
$-8 |
| 2021 |
$-8 |
| 2020 |
$-7 |
| 2019 |
$-9 |
| 2018 |
$-13 |
| 2017 |
$-13 |
| 2016 |
$-3 |
| 2015 |
$0 |
| 2014 |
$3 |
| 2013 |
$3 |
| 2012 |
$-1 |
| 2011 |
$2 |
| 2010 |
$1 |
| 2009 |
$1 |
IRIDEX Quarterly Operating Income
(Millions of US $) |
| 2023-12-31 |
$-3 |
| 2023-09-30 |
$-2 |
| 2023-06-30 |
$-3 |
| 2023-03-31 |
$-2 |
| 2022-12-31 |
$-1 |
| 2022-09-30 |
$-2 |
| 2022-06-30 |
$-2 |
| 2022-03-31 |
$-2 |
| 2021-12-31 |
$-2 |
| 2021-09-30 |
$-2 |
| 2021-06-30 |
$-1 |
| 2021-03-31 |
$-2 |
| 2020-12-31 |
$-0 |
| 2020-09-30 |
$-2 |
| 2020-06-30 |
$-3 |
| 2020-03-31 |
$-2 |
| 2019-12-31 |
$-2 |
| 2019-09-30 |
$-2 |
| 2019-06-30 |
$-2 |
| 2019-03-31 |
$-3 |
| 2018-12-31 |
$-3 |
| 2018-09-30 |
$-3 |
| 2018-06-30 |
$-3 |
| 2018-03-31 |
$-4 |
| 2017-12-31 |
$-5 |
| 2017-09-30 |
$-3 |
| 2017-06-30 |
$-3 |
| 2017-03-31 |
$-2 |
| 2016-12-31 |
$-1 |
| 2016-09-30 |
$-1 |
| 2016-06-30 |
$-0 |
| 2016-03-31 |
$0 |
| 2015-12-31 |
$0 |
| 2015-09-30 |
$0 |
| 2015-06-30 |
$-1 |
| 2015-03-31 |
$0 |
| 2014-12-31 |
$1 |
| 2014-09-30 |
$1 |
| 2014-06-30 |
$0 |
| 2014-03-31 |
$1 |
| 2013-12-31 |
$1 |
| 2013-09-30 |
$1 |
| 2013-06-30 |
$1 |
| 2013-03-31 |
$1 |
| 2012-12-31 |
$0 |
| 2012-09-30 |
$-1 |
| 2012-06-30 |
$-0 |
| 2012-03-31 |
$-0 |
| 2011-12-31 |
$1 |
| 2011-09-30 |
$0 |
| 2011-06-30 |
$0 |
| 2011-03-31 |
$0 |
| 2010-12-31 |
$-0 |
| 2010-09-30 |
$1 |
| 2010-06-30 |
$0 |
| 2010-03-31 |
$1 |
| 2009-12-31 |
$-1 |
| 2009-09-30 |
$1 |
| 2009-06-30 |
$0 |
| 2009-03-31 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Laser Systems and Components |
$0.049B |
$0.052B |
|
IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market.
|
